Asia Pacific Bioproduction Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2030

Analysis - by Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), and End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others)

No. of Pages: 117
Report Code: BMIRE00030060
Category: Life Sciences
Asia Pacific Bioproduction Market

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Data Triangulation and Validation

4. Asia Pacific Bioproduction Market Landscape

4.1 Overview
4.3 Ecosystem Analysis
  • 4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Bioproduction Market – Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints

6. Asia Pacific Bioproduction Market Regional Analysis

6.2 Asia Pacific Bioproduction Market Revenue 2020-2030 (US$ Million)
6.3 Asia Pacific Bioproduction Market Forecast Analysis

7. Asia Pacific Bioproduction Market Analysis – by Product

7.1 Biologics and Biosimilars
  • 7.1.1 Overview
  • 7.1.2 Biologics and Biosimilars: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.2 Vaccines
  • 7.2.1 Overview
  • 7.2.2 Vaccines: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.3 Cell and Gene Therapies
  • 7.3.1 Overview
  • 7.3.2 Cell and Gene Therapies: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
7.4 Nucleic Acid Therapeutics
  • 7.4.1 Overview
  • 7.4.2 Nucleic Acid Therapeutics: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

8. Asia Pacific Bioproduction Market Analysis – by Application

8.1 Rheumatoid Arthritis
  • 8.1.1 Overview
  • 8.1.2 Rheumatoid Arthritis: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.2 Hematological Disorders
  • 8.2.1 Overview
  • 8.2.2 Hematological Disorders: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.3 Cancer
  • 8.3.1 Overview
  • 8.3.2 Cancer: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.4 Diabetes
  • 8.4.1 Overview
  • 8.4.2 Diabetes: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
8.5 Cardiovascular Diseases
  • 8.5.1 Overview
  • 8.5.2 Cardiovascular Diseases: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

9. Asia Pacific Bioproduction Market Analysis – by Equipment

9.1 Upstream Equipment
  • 9.1.1 Overview
  • 9.1.2 Upstream Equipment: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.2 Downstream Equipment
  • 9.2.1 Overview
  • 9.2.2 Downstream Equipment: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.3 Bioreactors
  • 9.3.1 Overview
  • 9.3.2 Bioreactors: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
9.4 Consumables and Accessories
  • 9.4.1 Overview
  • 9.4.2 Consumables and Accessories: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

10. Asia Pacific Bioproduction Market Analysis – by End User

10.1 Biopharmaceutical Companies
  • 10.1.1 Overview
  • 10.1.2 Biopharmaceutical Companies: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)
10.2 Contract Manufacturing Organizations
  • 10.2.1 Overview
  • 10.2.2 Contract Manufacturing Organizations: Asia Pacific Bioproduction Market – Revenue and Forecast, 2020-2030 (US$ Million)

11. Asia Pacific Bioproduction Market – Asia-Pacific Analysis

11.1 Overview

11.2 Asia-Pacific
  • 11.2.1 Asia Pacific Bioproduction Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 11.2.1.1 Asia Pacific Bioproduction Market – Revenue and Forecast Analysis – by Country
  • 11.2.1.1 China: Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.1.1 China: Asia Pacific Bioproduction Market Breakdown, by Product
    • 11.2.1.1.2 China: Asia Pacific Bioproduction Market Breakdown, by Application
    • 11.2.1.1.3 China: Asia Pacific Bioproduction Market Breakdown, by Equipment
    • 11.2.1.1.4 China: Asia Pacific Bioproduction Market Breakdown, by End User
  • 11.2.1.2 India: Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.2.1 India: Asia Pacific Bioproduction Market Breakdown, by Product
    • 11.2.1.2.2 India: Asia Pacific Bioproduction Market Breakdown, by Application
    • 11.2.1.2.3 India: Asia Pacific Bioproduction Market Breakdown, by Equipment
    • 11.2.1.2.4 India: Asia Pacific Bioproduction Market Breakdown, by End User
  • 11.2.1.3 Japan: Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.3.1 Japan: Asia Pacific Bioproduction Market Breakdown, by Product
    • 11.2.1.3.2 Japan: Asia Pacific Bioproduction Market Breakdown, by Application
    • 11.2.1.3.3 Japan: Asia Pacific Bioproduction Market Breakdown, by Equipment
    • 11.2.1.3.4 Japan: Asia Pacific Bioproduction Market Breakdown, by End User
  • 11.2.1.4 Australia: Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.4.1 Australia: Asia Pacific Bioproduction Market Breakdown, by Product
    • 11.2.1.4.2 Australia: Asia Pacific Bioproduction Market Breakdown, by Application
    • 11.2.1.4.3 Australia: Asia Pacific Bioproduction Market Breakdown, by Equipment
    • 11.2.1.4.4 Australia: Asia Pacific Bioproduction Market Breakdown, by End User
  • 11.2.1.5 Rest of Asia-Pacific : Asia Pacific Bioproduction Market – Revenue and Forecast to 2030 (US$ Million)
    • 11.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Bioproduction Market Breakdown, by Product
    • 11.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Bioproduction Market Breakdown, by Application
    • 11.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Bioproduction Market Breakdown, by Equipment
    • 11.2.1.5.4 Rest of Asia-Pacific : Asia Pacific Bioproduction Market Breakdown, by End User

12. Competitive Landscape

12.1 Heat Map Analysis
12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview
13.2 Market Initiative
13.3 Partnerships and Collaborations
13.4 Other Developments

14. Company Profiles

14.1 Lonza Group AG
  • 14.1.1 Key Facts
  • 14.1.2 Business Description
  • 14.1.3 Products and Services
  • 14.1.4 Financial Overview
  • 14.1.5 SWOT Analysis
  • 14.1.6 Key Developments
14.2 bbi-biotech GmbH
  • 14.2.1 Key Facts
  • 14.2.2 Business Description
  • 14.2.3 Products and Services
  • 14.2.4 Financial Overview
  • 14.2.5 SWOT Analysis
  • 14.2.6 Key Developments
14.3 Danaher Corp
  • 14.3.1 Key Facts
  • 14.3.2 Business Description
  • 14.3.3 Products and Services
  • 14.3.4 Financial Overview
  • 14.3.5 SWOT Analysis
  • 14.3.6 Key Developments
14.4 Sartorius AG
  • 14.4.1 Key Facts
  • 14.4.2 Business Description
  • 14.4.3 Products and Services
  • 14.4.4 Financial Overview
  • 14.4.5 SWOT Analysis
  • 14.4.6 Key Developments
14.5 FUJIFILM Irvine Scientific Inc
  • 14.5.1 Key Facts
  • 14.5.2 Business Description
  • 14.5.3 Products and Services
  • 14.5.4 Financial Overview
  • 14.5.5 SWOT Analysis
  • 14.5.6 Key Developments
14.6 Thermo Fisher Scientific Inc
  • 14.6.1 Key Facts
  • 14.6.2 Business Description
  • 14.6.3 Products and Services
  • 14.6.4 Financial Overview
  • 14.6.5 SWOT Analysis
  • 14.6.6 Key Developments
14.7 Merck KGaA
  • 14.7.1 Key Facts
  • 14.7.2 Business Description
  • 14.7.3 Products and Services
  • 14.7.4 Financial Overview
  • 14.7.5 SWOT Analysis
  • 14.7.6 Key Developments
14.8 F. Hoffmann-La Roche Ltd
  • 14.8.1 Key Facts
  • 14.8.2 Business Description
  • 14.8.3 Products and Services
  • 14.8.4 Financial Overview
  • 14.8.5 SWOT Analysis
  • 14.8.6 Key Developments
14.9 Bio-Rad Laboratories Inc
  • 14.9.1 Key Facts
  • 14.9.2 Business Description
  • 14.9.3 Products and Services
  • 14.9.4 Financial Overview
  • 14.9.5 SWOT Analysis
  • 14.9.6 Key Developments

15. Appendix

15.1 About Business Market Insights
15.2 List of Abbreviations

The List of Companies - Asia Pacific Bioproduction Market

  • Lonza Group AG
  • bbi-biotech GmbH
  • Danaher Corp
  • Sartorius AG
  • FUJIFILM Irvine Scientific Inc
  • Thermo Fisher Scientific Inc
  • Merck KGaA
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Available Report Formats

    pdf-format excel-format pptx-format
    Buy Now
    Customization Form

    Please tell us your area of interest
    (Market Segments/ Regions and Countries/ Companies)